Ulp2 associates with actively transcribed genes, as demonstrated by chromatin immunoprecipitation (ChIP) assays:
| Gene | Ulp2 Occupancy (ORF Region) | RNAPII Association | Reference |
|---|---|---|---|
| PMA1 | High | Strong | |
| ADH1 | Moderate | Moderate | |
| PYK1 | High | Strong | |
| CUP1 | Inducible (copper-dependent) | Dynamic |
Ulp2 recruitment to CUP1 increases ~15-fold within 5 minutes of copper induction, paralleling RNAPII dynamics .
Ulp2 exhibits synthetic lethality with ctk1Δ (a CTD kinase mutant), indicating functional synergy in CTD phosphorylation .
Ulp2 promotes serine-2 phosphorylation (S2-P) of the RNAPII CTD, critical for transcription elongation:
Key findings:
Ulp2 antibodies are used in:
Western blotting to detect SUMO protease activity and protein expression levels.
Co-immunoprecipitation to study interactions with RNAPII subunits or chromatin modifiers.
Antibody validation: Requires specificity tests (e.g., knockout controls) to confirm target recognition .
Epitope tags: Many studies use epitope-tagged Ulp2 (e.g., FLAG) for precise localization .
While Ulp2 is yeast-specific, its mammalian homologs (e.g., SENP6/7) are implicated in:
STRING: 6239.Y38A8.3
UniGene: Cel.14116
How to resolve contradictions between ulp-2 antibody performance in different assays?
Example discrepancy: Strong signal in western blot but weak in IHC.
Analysis steps:
| Assay | Common Pitfalls | Validation Strategy |
|---|---|---|
| Western Blot | Denaturation artifacts | Compare recombinant vs. endogenous protein migration |
| IHC | Epitope masking | Optimize antigen retrieval buffers (e.g., citrate vs. EDTA) |
| Flow Cytometry | Conformational sensitivity | Test fixation/permeabilization protocols |
What experimental designs mitigate cross-reactivity risks in ulp-2 studies?
How to optimize ulp-2 antibody use in multiplex assays (e.g., Co-IP or proximity ligation)?
What statistical approaches strengthen ulp-2 antibody-based quantification?
How to interpret ulp-2 antibody results in the context of post-translational modifications (PTMs)?
Can ulp-2 antibodies be repurposed for structural biology studies (e.g., Cryo-EM)?
What are the limitations of ulp-2 antibodies in single-cell sequencing workflows?